ישראל -
עברית -
Ministry of Health
medical disposable devices
דין דיאגנוסטיקה בע"מ - אחות - infusion and transfusion therapy
ישראל -
עברית -
Ministry of Health
extension tubes for infusion
טבע מדיקל (שיווק) בע"מ - כלל האוכלוסיה - צינורות להארכת סטים לעירוי
ישראל -
עברית -
Ministry of Health
medical devices for infusion,drainage,angiography and angioplasty
י.גיל מדיקל בע"מ - רופא - מוצרים נלווים לחדר צנתורים ולחדרי אנג'יו
ישראל -
עברית -
Ministry of Health
גרניסטרון טבע
teva pharmaceutical indust.ltd - granisetron as hydrochloride 3 mg / 3 ml - solution for infusion - granisetron - for the prevention and control of nausea and vomiting induced by cytostatic therapy (chemotherapy and radiotherapy).
ישראל -
עברית -
Ministry of Health
אימנד 150 מ"ג iv
merck sharp & dohme israel ltd - fosaprepitant as fosaprepitant dimeglumine 150 mg - powder for solution for infusion - aprepitant - emend iv 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
ישראל -
עברית -
Ministry of Health
סרזים 200 יחידות
sanofi - aventis israel ltd - imiglucerase 200 u/vial - powder for solution for infusion - imiglucerase - for the long term enzyme replacement therapy for patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions: - anemia , - thrombocytopenia , - bone disease , - hepatomegaly or splenomegaly.
ישראל -
עברית -
Ministry of Health
פברזיים 5 מ"ג
sanofi - aventis israel ltd - agalsidase beta 5 mg/ml - powder for concentrate for infusion - agalsidase beta - long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease.
ישראל -
עברית -
Ministry of Health
ויפריב 400
takeda israel ltd - velaglucerase alfa - lyophilized powder for infusion - velaglucerase alfa 400 u/vial - velaglucerase alfa - velaglucerase alfa - vpriv is a hydrolytic glucocerebroside – specific enzyme indicated for the long term replacement therapy (ert) for pediatric and adult patients with type 1 gaucher disease.
ישראל -
עברית -
Ministry of Health
אפופרוסטנול טבע ® 1.5 מ"ג
salomon,levin & elstein ltd - epoprostenol as sodium 1.5 mg - powder and solvent for solution for infusion - epoprostenol - epoprostenol teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.
ישראל -
עברית -
Ministry of Health
אפופרוסטנול טבע ® 0.5 מ"ג
salomon,levin & elstein ltd - epoprostenol as sodium 0.5 mg - powder and solvent for solution for infusion - epoprostenol - epoprostenol teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.